pexels-adrien-olichon-1257089-3137078.jpg

Development Leadership across the program lifecycle

Archentis Partners provides integrated leadership across the drug development lifecycle, helping life science organizations translate scientific innovation into structured, execution-ready development programs. Our services span development strategy, program leadership, operational partnerships, and regulatory submission governance.

Development Strategy and Planning

Successful development programs begin with a clearly defined strategy that aligns scientific objectives with regulatory pathways and operational execution. Archentis Partners works with leadership teams to design integrated development strategies and plans that define the most efficient path from early development through regulatory submission. By structuring programs around clear milestones, critical path activities, and strategic decision points, we help organizations make informed choices about program direction, resource allocation, and long-term development investment.

Development Program Leadership

Complex drug development programs require disciplined leadership to align strategy, teams, and execution across multiple functions. Archentis provides embedded program leadership to guide cross-functional development efforts, establish effective governance structures, and maintain alignment around critical milestones. By integrating program planning, decision frameworks, and risk management, we help organizations advance development programs with clarity, accountability, and execution discipline.

Development Operations & Alliance Management

Effective drug development increasingly relies on a network of external partners, including contract research organizations, manufacturing partners, academic collaborators, and specialized experts. Archentis Partners helps organizations structure and manage these relationships to ensure that external activities remain tightly aligned with program strategy, development timelines, and regulatory objectives.

We establish governance frameworks, oversee vendor performance, and guide outsourcing strategies that enable organizations to scale development capabilities while maintaining clear accountability and operational discipline across complex partner ecosystems.

Regulatory Submission Governance

Regulatory submissions represent some of the most critical milestones in a development program and require disciplined planning, coordination, and governance across multiple functions. Archentis Partners helps organizations structure regulatory strategies and submission plans that align clinical, nonclinical, CMC, and operational activities around clearly defined regulatory objectives. Through integrated planning, cross-functional coordination, and proactive risk management, we support teams in navigating complex regulatory pathways and preparing high-quality submissions with confidence.

Investor Advisory & Development Diligence

Archentis Partners supports investors, boards, and strategic partners in evaluating the strength, feasibility, and execution readiness of drug development programs.

We provide structured, independent assessments of development strategy, execution risk, timelines, and capital requirements—helping investors understand the path to key value inflection points and regulatory approval.

Areas of Focus

  • Development strategy and integrated plan assessment

  • Execution risk and operational readiness

  • Timeline and milestone feasibility

  • Capital requirement and funding analysis

Strategy | Leadership | Partnerships

If your organization is preparing to advance a development program or navigate a critical regulatory milestone, we welcome the opportunity to discuss how Archentis Partners can support your team.